Infinity Pharmaceuticals, Inc. (INFIQ)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Aug 25, 2026, 4:00 PM EST

Infinity Pharmaceuticals Revenue

Infinity Pharmaceuticals had revenue of $583.00K in the quarter ending June 30, 2023, a decrease of -15.01%. This brings the company's revenue in the last twelve months to $2.57M, up 15.88% year-over-year. In the year 2022, Infinity Pharmaceuticals had annual revenue of $2.59M with 39.56% growth.

Revenue (ttm)
2.57M
Revenue Growth
+15.88%
P/S Ratio
0.00
Revenue / Employee
85.63K
Employees
30
Market Cap
91.00

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20222.59M735.00K39.56%
Dec 31, 20211.86M139.00K8.09%
Dec 31, 20201.72M-1.33M-43.62%
Dec 31, 20193.05M-19.10M-86.23%
Dec 31, 201822.15M16.15M269.10%
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Dec 31, 2013 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
RVL Pharmaceuticals36.92M
Gelesis Holdings12.14M
Seelos Therapeutics2.01M
Genocea Biosciences1.91M
Cardax500.71K
Marizyme183.42K
Athersys80.00K
Revenue Rankings